2017
DOI: 10.3892/br.2017.1014
|View full text |Cite
|
Sign up to set email alerts
|

Mutation analysis of Leber's hereditary optic neuropathy using a multi‑gene panel

Abstract: Abstract. The present study investigates the spectrum and incidence of mitochondrial DNA (mtDNA) mutations associated with Leber's hereditary optic neuropathy (LHON) in a Han population using a multi-gene panel with 46 LHON-associated mutations among 13 mitochondrial genes. A total of 23 mutations were observed in a cohort of 275 patients and 281 control subjects using multi-gene panel analysis IntroductionLeber's hereditary optic neuropathy (LHON; OMIM 535000) is a classic mitochondrial disease, associated… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
26
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 30 publications
(36 citation statements)
references
References 30 publications
3
26
0
Order By: Relevance
“…Screening for the presence of other proven pathogenic variants in mtDNA, both point mutations and large deletions, brought negative results, implying that such deleterious changes do not contribute to disease development. Nevertheless, we identified three non-synonymous variants reported previously to associate with LHON (Fauser et al 2002;Abu-Amero and Bosley 2006;Dai et al 2018). However, their role in disease development in a synergistic mechanism, as an additional, secondary mutation, in three Table 4 Number of transitions (T S ), transversions (T V ), and their ratio in particular mtDNA regions in male LHON patients and control subjects.…”
Section: Discussionmentioning
confidence: 84%
See 1 more Smart Citation
“…Screening for the presence of other proven pathogenic variants in mtDNA, both point mutations and large deletions, brought negative results, implying that such deleterious changes do not contribute to disease development. Nevertheless, we identified three non-synonymous variants reported previously to associate with LHON (Fauser et al 2002;Abu-Amero and Bosley 2006;Dai et al 2018). However, their role in disease development in a synergistic mechanism, as an additional, secondary mutation, in three Table 4 Number of transitions (T S ), transversions (T V ), and their ratio in particular mtDNA regions in male LHON patients and control subjects.…”
Section: Discussionmentioning
confidence: 84%
“…No other proven pathogenic variants were found either in LHON patients or control individuals. However, three distinct mtDNA variants reported previously to associate with LHON (Fauser et al 2002;Abu-Amero and Bosley 2006;Dai et al 2018) were identified in three different patients and one control subject, in all in the homoplasmic state, and are shown in more detail in Table 1. All three variants define haplogroups on the background of which they were detected in patients (Oven and Kayser 2009).…”
Section: Proven Pathogenic Variantsmentioning
confidence: 89%
“…The damage and eventual loss of RGCs in DOA are caused by the progressive impairment of mitochondrial oxidation and the lack of energy production in the form of ATP through the mitochondrial respiratory chain. Causative mutations for LHON affect members of the gene family encoding the mitochondrially encoded NADH: Ubiquinone oxidoreductase core subunits ( MT-ND1, MT-ND4, MT-ND5 and MT-ND6 )[ 7 ]. These mutations affect complex 1 of the electron transport chain of the mitochondria and manifest in failure of oxidative pho-sphorylation accompanied by impaired or absent ATP production.…”
Section: Introductionmentioning
confidence: 99%
“…Leber's hereditary optic neuropathy (LHON) is one of the most common mitochondrial DNA (mtDNA) diseases, which is characterized by acute or subacute bilateral central vision loss due to selective death of retinal ganglion cells (RGCs) and optic atrophy 13. The disease is typically detected in young adults and more frequently affects males, predominantly 4.…”
Section: Introductionmentioning
confidence: 99%